BRIDGEBIO PHARMA INC (BBIO) Institutional Ownership and Insiders Activity

BRIDGEBIO PHARMA INC (BBIO) is widely held by institutional investors, with 454 firms reporting positions valued at approximately $11.68B based on SEC Form 13F filings for the quarter ended September 30, 2026.

Janus Henderson Group Plc is the largest disclosed holder, reporting approximately $957.70M in BBIO holdings in its latest filing.

Recent insider activity includes 10 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.

Institutional Holders

454

Total Reported Value

$11.68B

Largest Holder

Janus Henderson Group Plc

Largest Position

$957.70M

Insider Transactions (90d)

10

Latest Filing Quarter

Q3 2026

New Institutional Positions

90

Funds Exiting Positions

57